Muscle Weakness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
536
|
87
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.100 |
None |
|
0 |
2
|
|
|
Short stature
|
phenotype |
|
Finding
|
1127
|
292
|
0.100 |
None |
|
0 |
|
|
|
Hearing Loss
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Finding
|
18
|
61
|
0.100 |
None |
|
0 |
14
|
|
|
Thyroid Hypoplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Endocrine System Diseases
|
Disease or Syndrome
|
14
|
6
|
0.410 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Thyroid Agenesis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Endocrine System Diseases
|
Congenital Abnormality
|
11
|
3
|
0.400 |
None |
1.000 |
1 |
|
2014 |
2014 |
Enlarged Vestibular Aqueduct
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Finding
|
4
|
|
0.400 |
strong |
1.000 |
1 |
|
2002 |
2002 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Mondini defect
|
disease |
|
Congenital Abnormality
|
1
|
|
0.300 |
strong |
1.000 |
1 |
|
2002 |
2002 |
Acidosis
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
28
|
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Sensorineural hearing loss, bilateral
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
117
|
30
|
0.110 |
None |
1.000 |
1 |
2
|
2015 |
2015 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.110 |
None |
1.000 |
1 |
|
2009 |
2009 |
Alkaline phosphatase measurement
|
phenotype |
|
Laboratory Procedure
|
42
|
79
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Oncocytoma, renal
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
34
|
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Adult myxedema
|
disease |
Skin and Connective Tissue Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mass of thyroid gland
|
disease |
Endocrine System Diseases
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Mental deterioration
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
508
|
121
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Goniodysgenesis
|
disease |
|
Congenital Abnormality
|
6
|
3
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Xanthomatosis, Cerebrotendinous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
40
|
71
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Epigastric pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
17
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Nontoxic goiter
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Mineralocorticoid Excess Syndrome, Apparent
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
8
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Medullary carcinoma of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
330
|
71
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |